Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · see citing works

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055 · see citing works

Reactive Oxygen Species and the Central Nervous System

Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947 · see citing works

El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis

Brooks, B. R. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90191-0 · Cited by 2,144 · see citing works

Unified Huntington's disease rating scale: Reliability and consistency

Kremer, H. P. H. (1996) · Movement Disorders · doi:10.1002/mds.870110204 · Cited by 2,109 · see citing works

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471 · see citing works

The measurement and mechanism of lipid peroxidation in biological systems

Gutteridge, J. M. C., & Halliwell, B. B. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90206-q · Cited by 1,292 · see citing works

Unified Huntington's disease rating scale: reliability and consistency

Kremer, H. P. H. (1996) · Radboud Repository (Radboud University) · Cited by 1,059 · see citing works

The Role of Copper in Neurodegenerative Disease

Waggoner, D., Bartnikas, T. B., & Gitlin, J. D. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0250 · Cited by 858 · see citing works

Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?

Ischiropoulos, H., & Beckman, J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317638 · Cited by 748 · see citing works

Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

Harris, Z. L., Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, R. T., & Gitlin, J. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2539 · Cited by 558 · cited 5× · see citing works

Clinical limits of amyotrophic lateral sclerosis.

Mulder, D. W. (1982) · PubMed · Cited by 444 · see citing works

The Amyotrophic Lateral Sclerosis Functional Rating Scale

(1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020045014 · Cited by 441 · see citing works

Neuronal degeneration and mitochondrial dysfunction

Schon, E. A., & Manfredi, G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17741 · Cited by 393 · see citing works

Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury

Patel, B. N., Dunn, R. J., Jeong, S. Y., Zhu, Q., Julien, J.-P., & David, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06578.2002 · Cited by 379 · see citing works

Neuronal degeneration and mitochondrial dysfunction

Schon, E. A., & Manfredi, G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317741 · Cited by 326 · see citing works

Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias

Moroney, J. T., Bagiella, E., Desmond, D. W., Hachinski, V. C., Mölsä, P. K., Gustafson, L., Brun, A., Fischer, P. D., Erkinjuntti, T., Rosen, W. G., et al. (1997) · Neurology · doi:10.1212/wnl.49.4.1096 · Cited by 316 · see citing works

Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species

Brookes, P. S., Levonen, A.-L., Shiva, S., Sarti, P., & Darley-Usmar, V. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00901-2 · Cited by 298 · see citing works

Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia

Dexter, D. T., Jenner, P. G., Schapira, A. H. V., & MARSDEN, C. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320716 · Cited by 292 · see citing works

New insights into the cause of Parkinson's disease

Jenner, P., Schapira, A. H. V., & MARSDEN, C. D. (1992) · Neurology · doi:10.1212/wnl.42.12.2241 · Cited by 272 · see citing works

RAISED CEREBROSPINAL-FLUID COPPER CONCENTRATION IN PARKINSON'S DISEASE

Pall, H., Blake, D. R., Gutteridge, J. M. C., Williams, A. C., Lunec, J., Hall, M., & Taylor, A. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90827-0 · Cited by 230 · see citing works

The start of a long debate on the Warnock report.

Deitch, R. (1984) · PubMed · Cited by 185 · see citing works

Copper and prion disease

Brown, D. R. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00453-1 · Cited by 161 · see citing works

The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.

(1996) · PubMed · Cited by 122 · see citing works

Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease

Hochstrasser, H., Bauer, P., Walter, U., Behnke, S., Spiegel, J., Csoti, I., Zeiler, B., Bornemann, A., Pahnke, J., Becker, G., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000144276.29988.c3 · Cited by 111 · see citing works

Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease

Boll, M.-C., Sotelo, J., Otero, E., Alcaraz-Zubeldia, M., & Rios, C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00221-9 · Cited by 92 · see citing works

Chapter 19 Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture

Estévez, Á. G., Spear, N., Manuel, S. M., Barbeito, L., Radí, R., & Beckman, J. S. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)63214-8 · Cited by 91 · see citing works

Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis

Corona, J. C., Tovar‐y‐Romo, L. B., & Tapia, R. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1415 · Cited by 91 · see citing works

Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer’s disease

Zoia, C., Cogliati, T., Tagliabue, E., Cavaletti, G., Sala, G., Galimberti, G., Rivolta, I., Rossi, V., Frattola, L., & Ferrarese, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00085-x · Cited by 85 · see citing works

New order from neurological disorders

Price, D. L. (1999) · Nature · doi:10.1038/399a003 · Cited by 82 · see citing works

Studies of Lipid Peroxidation Products in Cerebrospinal Fluid and Serum in Multiple Sclerosis and Other Conditions

Naidoo, R., & Knapp, M. L. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.12.2449 · Cited by 77 · see citing works

The role of iron in the basal ganglion.

Youdim, M. B. H., Ben‐Shachar, D., Yehuda, S., & Riederer, P. F. (1990) · PubMed · Cited by 55 · see citing works

Neuroprotective Effect of Acute and Chronic Administration of Copper (II) Sulfate against MPP+ Neurotoxicity in Mice

Alcaraz-Zubeldia, M., Rojas, P., Boll, C., & Rı́os, C. (2001) · Neurochemical Research · doi:10.1023/a:1007680616056 · Cited by 48 · see citing works

Depletion of Copper and Manganese in Brain after MPTP Treatment of Mice

Rı́os, C., Alvarez-Vega, R., & Rojas, P. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00160.x · Cited by 35 · see citing works

Involvement of amyloid β precursor protein (AβPP) modulated copper homeostasis in Alzheimer's disease

Bayer, T. A., & Multhaup, G. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8212 · Cited by 32 · see citing works

Raised Nitrate Concentration and Low SOD Activity in the CSF of Sporadic ALS Patients

Boll, M., Alcaraz-Zubeldia, M., Montes, S., Murillo-Bonilla, L. M., & Rı́os, C. (2003) · Neurochemical Research · doi:10.1023/a:1022853531855 · Cited by 27 · see citing works

Nitrite and nitrate levels in cerebrospinal fluid of normal subjects

Zecca, L., Rosati, M., Renella, R. R., Galimberti, M., Ambrosini, A., & Fariello, R. G. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050084 · Cited by 25 · see citing works

Analysis of the (CAG)n repeat causing Huntington's disease in a Mexican population

Alonso, M. E., Yescas, P., Cisneros, B., Martínez, C., Silva, G., Ochoa, A., & Montáñez, C. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02459.x · Cited by 25 · see citing works

The role of iron in brain ageing and neurodegenerative disorders

Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819 · see citing works

Oxidative Stress in Neurodegenerative Diseases

Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377 · see citing works

Oxidative Stress in Neurodegenerative Diseases

Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9337-5 · Cited by 800 · see citing works

Environmental-induced oxidative stress in neurodegenerative disorders and aging

Migliore, L., & Coppedè, F. (2008) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2008.09.013 · Cited by 396 · see citing works

Functions and dysfunctions of nitric oxide in brain

Picón-Pagès, P., Garcia-Buendia, J., & Muñoz, F. J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.007 · Cited by 357 · see citing works

Oxidative damage to macromolecules in human Parkinson disease and the rotenone model

Sanders, L. H., & Greenamyre, J. T. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.003 · Cited by 347 · see citing works

Copper complexes as therapeutic agents

Duncan, C., & White, A. R. (2011) · Metallomics · doi:10.1039/c2mt00174h · Cited by 293 · see citing works

Metals and neurodegenerative diseases. A systematic review

Cicero, C. E., Mostile, G., Vasta, R., Rapisarda, V., Signorelli, S. S., Ferrante, M., Zappia, M., & Nicoletti, A. S. Q. (2017) · Environmental Research · doi:10.1016/j.envres.2017.07.048 · Cited by 269 · see citing works

Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease

Ayton, S., Lei, P., Duce, J. A., Wong, B. X. W., Sedjahtera, A., Adlard, P. A., Bush, A. I., & Finkelstein, D. I. (2013) · Annals of Neurology · doi:10.1002/ana.23817 · Cited by 264 · see citing works

The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases

Dušek, P., Roos, P. M., Litwin, T., Schneider, S. A., Flaten, T. P., & Aaseth, J. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.05.007 · Cited by 253 · see citing works

The transition metals copper and iron in neurodegenerative diseases

Rivera-Mancía, S., Pérez‐Neri, I., Rı́os, C., Tristán-López, L. A., Rivera-Espinosa, L., & Montes, S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.010 · Cited by 243 · see citing works

Physical activity and the brain: A review of this dynamic, bi-directional relationship

Loprinzi, P. D., Herod, S. M., Cardinal, B. J., & Noakes, T. D. (2013) · Brain Research · doi:10.1016/j.brainres.2013.10.004 · Cited by 223 · see citing works

Copper and Copper Proteins in Parkinson’s Disease

Montes, S., Rivera-Mancia, S., Diaz-Ruiz, A., Tristan-Lopez, L., & Rios, C. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/147251 · Cited by 203 · see citing works

Metal ions, Alzheimer's disease and chelation therapy

Budimir, A. (2011) · Acta Pharmaceutica · doi:10.2478/v10007-011-0006-6 · Cited by 202 · see citing works

Cerebral bioimaging of Cu, Fe, Zn, and Mn in the MPTP mouse model of Parkinson’s disease using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS)

Matusch, A., Depboylu, C., Palm, C., Wu, B., Höglinger, G. U., Schäfer, M. K.-H., & Becker, J. S. (2009) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2009.09.022 · Cited by 197 · see citing works

The impact of high and low dose ionising radiation on the central nervous system

Betlazar, C., Middleton, R., Banati, R., & Liu, G.-J. (2016) · Redox Biology · doi:10.1016/j.redox.2016.08.002 · Cited by 126 · see citing works

Copper in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies

Bucossi, S., Ventriglia, M., Panetta, V., Salustri, C., Pasqualetti, P., Mariani, S., Siotto, M., Rossini, P. M., & Squitti, R. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101473 · Cited by 183 · see citing works

Oxidative Stress Gated by Fenton and Haber Weiss Reactions and Its Association With Alzheimer’s Disease

Kanti Das, T., Wati, M. R., & Fatima-Shad, K. (2014) · Archives of Neuroscience · doi:10.5812/archneurosci.20078 · Cited by 177 · see citing works

Nigral Iron Elevation Is an Invariable Feature of Parkinson’s Disease and Is a Sufficient Cause of Neurodegeneration

Ayton, S., & Lei, P. (2014) · BioMed Research International · doi:10.1155/2014/581256 · Cited by 161 · see citing works

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

Morris, G., Berk, M., Carvalho, A. F., Maes, M. H. J., Walker, A. J., & Puri, B. K. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.036 · Cited by 154 · see citing works

Metal Dyshomeostasis and Inflammation in Alzheimer’s and Parkinson’s Diseases: Possible Impact of Environmental Exposures

Myhre, O., Utkilen, H., Duale, N., Brunborg, G., & Hofer, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/726954 · Cited by 152 · see citing works

Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease

Šimunović, F., Yi, M., Wang, Y., Stephens, R. M., & Sonntag, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008856 · Cited by 141 · see citing works

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers

Ottervald, J., Franzén, B., Nilsson, K. C., Andersson, L. I., Khademi, M., Eriksson, B., Kjellström, S., Marko‐Varga, G., Végvári, Á., Harris, R. A., et al. (2010) · Journal of Proteomics · doi:10.1016/j.jprot.2010.01.004 · Cited by 141 · see citing works

Association between Heavy Metal Exposure and Parkinson’s Disease: A Review of the Mechanisms Related to Oxidative Stress

Pyatha, S., Kim, H., Lee, D., & Kim, K. (2022) · Antioxidants · doi:10.3390/antiox11122467 · Cited by 140 · see citing works

Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics

Davies, K. M., Mercer, J. F. B., Chen, N., & Double, K. L. (2016) · Clinical Science · doi:10.1042/cs20150153 · Cited by 134 · see citing works

Physical exercise as a possible strategy for brain protection: Evidence from mitochondrial-mediated mechanisms

Marques‐Aleixo, I., Oliveira, P. J., Moreira, P. I., Magalhães, J., & Ascensão, A. A. M. R. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.08.002 · Cited by 132 · see citing works

Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention

Olivieri, S., Conti, A., Iannaccone, S., Cannistraci, C. V., Campanella, A., Barbariga, M., Codazzi, F., Pelizzoni, I., Magnani, G., Pesca, M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3768-11.2011 · Cited by 125 · see citing works

Iron dysregulation in Huntington's disease

Müller, M., & Leavitt, B. R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12739 · Cited by 122 · see citing works

Abnormal Copper Homeostasis: Mechanisms and Roles in Neurodegeneration

Manto, M. U. (2014) · Toxics · doi:10.3390/toxics2020327 · Cited by 118 · see citing works

Copper handling by astrocytes: Insights into neurodegenerative diseases

Tiffany‐Castiglioni, E., Hong, S. J., & Qian, Y. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.09.004 · Cited by 115 · see citing works

Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review

Andersen, A. D., Binzer, M., Stenager, E., & Gramsbergen, J. B. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12590 · Cited by 116 · see citing works

Metal Binding Dictates Conformation and Function of the Amyloid Precursor Protein (APP) E2 Domain

Dahms, S. O., Könnig, I., Roeser, D., Gührs, K., Mayer, M., Kaden, D., Multhaup, G., & Than, M. E. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.057 · Cited by 110 · see citing works

Cerebral blood flow regulation by nitric oxide in neurological disorders

Toda, N., Ayajiki, K., & Okamura, T. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-048 · Cited by 107 · see citing works

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease

Sagredo, O., Pazos, M. R., Satta, V., Ramos, J. A., Pertwee, R. G., & Fernández‐Ruiz, J. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22682 · Cited by 105 · see citing works

Copper-64: a real theranostic agent

Gutfilen, B., de Souza, S. A. L., & Valentini, G. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s170879 · Cited by 100 · see citing works

Important Role of Oxidative Stress Biomarkers in Huntington’s Disease

Túnez, I., Sánchez‐López, F., Agüera, E., Fernández‐Bolaños, R., Sánchez, F. M., & Tasset-Cuevas, I. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200605a · Cited by 93 · see citing works

Oxidative stress and inflammation biomarkers in the blood of patients with Huntington’s disease

Sánchez‐López, F., Tasset, I., Agüera, E., Feijóo, M., Fernández‐Bolaños, R., Sánchez, F. M., Ruiz, M. C., Cruz, A. H., Gascón, F., & Túnez, I. (2012) · Neurological Research · doi:10.1179/1743132812y.0000000073 · Cited by 87 · see citing works

Selenium and Other Trace Elements in the Etiology of Parkinson’s Disease: A Systematic Review and Meta-Analysis of Case-Control Studies

Adani, G., Filippini, T., Michalke, B., & Vinceti, M. (2019) · Neuroepidemiology · doi:10.1159/000502357 · Cited by 83 · see citing works

Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

Jiménez-Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., & Agúndez, J. A. G. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00369 · Cited by 83 · see citing works

Metals in alzheimer's disease: a systemic perspective

Squitti, R. (2011) · Frontiers in bioscience · doi:10.2741/3938 · Cited by 79 · see citing works

Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis

Tokuda, E., Takei, Y.-I., Ohara, S., Fujiwara, N., Hozumi, I., & Furukawa, Y. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0341-5 · Cited by 80 · see citing works

Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson’s disease

Ayton, S., Lei, P., Adlard, P. A., Volitakis, I., Cherny, R. A., Bush, A. I., & Finkelstein, D. I. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-27 · Cited by 79 · see citing works

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats

Peres, F. F., Levin, R. R., Suiama, M. A., Diana, M. C., Gouvêa, D. A., de Almeida, V., Santos, C. M., Lungato, L., Zuardi, A. W., Hallak, J. E. C., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00343 · Cited by 77 · see citing works

Oxidative Stress in Neurodegenerative Diseases

Simonian, N. A. (1996) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.36.1.83 · Cited by 74 · see citing works

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach

van Dijk, K. D., Teunissen, C. E., Drukarch, B., Jiménez, C. R., Groenewegen, H. J., Berendse, H. W., & van de Berg, W. D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.020 · Cited by 72 · see citing works

Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity

Kumar, P., Kalonia, H., & Kumar, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.11.030 · Cited by 69 · see citing works

Heterogeneity of nervous system mitochondria: Location, location, location!

Dubinsky, J. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.020 · Cited by 66 · see citing works

Neuroprotective effect of hemeoxygenase-1/glycogen synthase kinase-3β modulators in 3-nitropropionic acid-induced neurotoxicity in rats

Khan, A. G., Jamwal, S., Bijjem, K. R. V., Prakash, A. K., & Kumar, P. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.018 · Cited by 65 · see citing works

The Potential for Transition Metal-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis

Lovejoy, D., & Guillemin, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00173 · Cited by 59 · see citing works

Salsolinol: an Unintelligible and Double-Faced Molecule—Lessons Learned from In Vivo and In Vitro Experiments

Kurnik‐Łucka, M., Panula, P., Bugajski, A. J., & Gil, K. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9818-6 · Cited by 64 · see citing works

Functional Aspects of Redox Control During Neuroinflammation

Rosales‐Corral, S., Reiter, R. J., Tan, D., Ortiz, G. G., & López-Armas, G. D. C. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2629 · Cited by 64 · see citing works

Cellular distribution of copper to superoxide dismutase involves scaffolding by membranes

Pope, C. R., Feo, C. J. D., & Unger, V. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309820110 · Cited by 59 · see citing works

Decreased NOS1 Expression in the Anterior Cingulate Cortex in Depression

Gao, S., Qi, X., Zhao, J., Balesar, R. A., Bao, A., & Swaab, D. F. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs285 · Cited by 59 · see citing works

What has fluorescent sensing told us about copper and brain malfunction?

Shen, C., & New, E. J. (2014) · Metallomics · doi:10.1039/c4mt00288a · Cited by 58 · see citing works

Copper imbalance in Alzheimer’s disease: Overview of the exchangeable copper component in plasma and the intriguing role albumin plays

Siotto, M., & Squitti, R. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.05.020 · Cited by 57 · see citing works

Non-ceruloplasmin bound copper and ATP7B gene variants in Alzheimer's disease

Squitti, R., Siotto, M., Arciello, M., & Rossi, L. C. (2016) · Metallomics · doi:10.1039/c6mt00101g · Cited by 56 · see citing works

Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects

Riccardis, L. D., Buccolieri, A., Muci, M., Pitotti, E., Robertis, F. D., Trianni, G., Manno, D. E., & Maffia, M. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.007 · Cited by 56 · see citing works

Ferroptosis as a Major Factor and Therapeutic Target for Neuroinflammation in Parkinson’s Disease

Ko, C.-J., Gao, S.-L., Lin, T.-K., Chu, P.-Y., & Lin, H.-Y. (2021) · Biomedicines · doi:10.3390/biomedicines9111679 · Cited by 54 · see citing works

PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper

Aboud, A. A., Tidball, A. M., Kumar, K. K., Neely, M. D., Han, B., Ess, K. C., Hong, C. C., Erikson, K. M., Hedera, P., & Bowman, A. B. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.002 · Cited by 49 · see citing works

Nucleic acid oxidative damage in Alzheimer's disease—explained by the hepcidin-ferroportin neuronal iron overload hypothesis?

Hofer, T., & Perry, G. L. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.06.005 · Cited by 49 · see citing works

Proximity to residential and workplace pesticides application and the risk of progression of Parkinson's diseases in Central California

Li, S., Ritz, B. R., Gong, Y., Cockburn, M., Folle, A. D., Rosario, I. D., Yu, Y., Zhang, K., Castro, E., Keener, A. M., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.160851 · Cited by 48 · see citing works

Metal Exposure and Risk of Parkinson Disease: A Systematic Review and Meta-Analysis

Zhao, Y., Ray, A., Portengen, L., Vermeulen, R. C. H., & Peters, S. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad082 · Cited by 47 · see citing works

Cerebrospinal Fluid Biomarkers in Parkinson’s Disease: A Critical Overview of the Literature and Meta-Analyses

Katayama, T., Sawada, J., Takahashi, K., & Yahara, O. (2020) · Brain Sciences · doi:10.3390/brainsci10070466 · Cited by 48 · see citing works

Ceruloplasmin functional changes in Parkinson’s disease-cerebrospinal fluid

Barbariga, M., Curnis, F., Andolfo, A., Zanardi, A., Lazzaro, M., Conti, A., Magnani, G., Volonté, M. A., Ferrari, L. D., Comı, G., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0055-2 · Cited by 44 · see citing works

Oxidative and nitrosative stress in serum of patients with Parkinson’s disease

Çubukçu, H. C., Yurtdaş, M., Durak, İ., Aytaç, B., Güneş, H. N., Çokal, B. G., Yoldaş, T. K., & Durak, İ. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2663-1 · Cited by 43 · see citing works

Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson’s disease and in hepatic encephalopathy

Siotto, M., Pasqualetti, P., Marano, M., & Squitti, R. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1196-0 · Cited by 42 · see citing works

Antioxidants rescue photoreceptors in rd1 mice: Relationship with thiol metabolism

Miranda, M., Arnal, E., Ahuja, S., Álvarez-Nölting, R., López‐Pedrajas, R., Ekström, P. A. R., Bosch‐Morell, F., Veen, T. V., & Romero, F. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.042 · Cited by 42 · see citing works

Shared perturbations in the metallome and metabolome of Alzheimer’s, Parkinson’s, Huntington’s, and dementia with Lewy bodies: A systematic review

Scholefield, M., Unwin, R. D., & Cooper, G. J. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101152 · Cited by 39 · see citing works

Copper phenotype in Alzheimer's disease: dissecting the pathway.

Squitti, R., & Polimanti, R. A. (2013) · Europe PMC (PubMed Central) · Cited by 39 · see citing works

Medical Management of Parkinsons Disease: Focus on Neuroprotection

Rı́os, C., Boll, M., & Alcaraz-Zubeldia, M. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596577 · Cited by 39 · see citing works

Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington’s-like symptoms: a comparative study

Kumar, P., Kalonia, H., & Kumar, A. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110364269 · Cited by 38 · see citing works

New Perspectives on Oxidized Genome Damage and Repair Inhibition by Pro-Oxidant Metals in Neurological Diseases

Mitra, J., Guerrero, E. N., Hegde, P. M., Wang, H., Boldogh, I. R., Rao, K. S. J., MITRA, S. P., & Hegde, M. L. (2014) · Biomolecules · doi:10.3390/biom4030678 · Cited by 37 · see citing works

NO Orchestrates the Loss of Synaptic Boutons from Adult “Sick” Motoneurons: Modeling a Molecular Mechanism

Moreno‐López, B., Sunico, C. R., & González‐Forero, D. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8159-8 · Cited by 36 · see citing works

Case–control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: A short review

Tórsdóttir, G., Kristinsson, J., Snædal, J., Sveinbjörnsdóttir, S., Guðmundsson, G., Hreiðarsson, S., & Jøhannesson, T. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.047 · Cited by 35 · see citing works

Involvement of CTR1 and ATP7A in lead (Pb)-induced copper (Cu) accumulation in choroidal epithelial cells

Zheng, G., Zhang, J., Xu, Y., Shen, X., Song, H. S., Jing, J., Luo, W., Zheng, W., & Chen, J. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.11.034 · Cited by 35 · see citing works

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease

Miyazaki, I., & Asanuma, M. (2023) · Antioxidants · doi:10.3390/antiox12040894 · Cited by 34 · see citing works

Fluctuating vs. Continuous Exposure to H2O2: The Effects on Mitochondrial Membrane Potential, Intracellular Calcium, and NF-κB in Astroglia

Bajić, A., Spasić, M. B., Anđjus, P. R., Savić, D. Z., Parabucki, A., Nikolić‐Kokić, A., & Spasojević, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076383 · Cited by 34 · see citing works

Alterations in metal homeostasis occur prior to canonical markers in Huntington disease

Pfalzer, A. C., Yan, Y., Kang, H., Totten, M. S., Silverman, J., Bowman, A. B., Erikson, K. M., & Claassen, D. O. (2022) · Scientific Reports · doi:10.1038/s41598-022-14169-y · Cited by 34 · see citing works

Protective role of fructose in the metabolism of astroglial C6 cells exposed to hydrogen peroxide

Spasojević, I., Bajić, A., Jovanović, K., Spasić, M. B., & Anđjus, P. R. (2009) · Carbohydrate Research · doi:10.1016/j.carres.2009.05.023 · Cited by 33 · see citing works

Neocortex and Allocortex Respond Differentially to Cellular Stress In Vitro and Aging In Vivo

Posimo, J. M., Titler, A. M., Choi, H. J. H., Unnithan, A. S., & Leak, R. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058596 · Cited by 33 · see citing works

Late-onset dietary restriction compensates for age-related increase in oxidative stress and alterations of HSP 70 and synapsin1 protein levels in male Wistar rats

Sharma, S., Singh, R., Kaur, M., & Kaur, G. (2009) · Biogerontology · doi:10.1007/s10522-009-9240-4 · Cited by 33 · see citing works

Relative contribution of CTR1 and DMT1 in copper transport by the blood–CSF barrier: Implication in manganese-induced neurotoxicity

Zheng, G., Chen, J., & Zheng, W. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.03.006 · Cited by 32 · see citing works

Bioavailability and catalytic properties of copper and iron for Fenton chemistry in human cerebrospinal fluid

Spasojević, I., Mojović, M., Stević, Z., Spasić, S. D., Jones, D. R., Morina, A., & Spasić, M. B. (2010) · Redox Report · doi:10.1179/174329210x12650506623087 · Cited by 32 · see citing works

Recent advances in CSF biomarkers for Parkinson's disease

LeWitt, P. A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70017-7 · Cited by 31 · see citing works

A comparison of ceruloplasmin to biological polyanions in promoting the oxidation of Fe2+ under physiologically relevant conditions

Wong, B. X. W., Ayton, S., Lam, L. Q., Lei, P., Adlard, P. A., Bush, A. I., & Duce, J. A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.08.006 · Cited by 31 · see citing works

Iron and copper in progressive demyelination – New lessons from Skogholt's disease

Aspli, K. T., Flaten, T. P., Roos, P. M., Holmøy, T., Skogholt, J. H., & Aaseth, J. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.12.002 · Cited by 32 · see citing works

Emerging insights into cuproptosis and copper metabolism: implications for age-related diseases and potential therapeutic strategies

Fan, H., Wang, K., Zhao, X., Song, B., Yao, T., Liu, T., Gao, G., Lu, W., & Liu, C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1335122 · Cited by 31 · see citing works

Intronic rs2147363 Variant in ATP7B Transcription Factor-Binding Site Associated with Alzheimer's Disease

Bucossi, S., Polimanti, R. A., Ventriglia, M., Mariani, S., Siotto, M., Ursini, F., Trotta, L., Scrascia, F., Callea, A., Vernieri, F., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130431 · Cited by 27 · see citing works

Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway

Aluf, Y., Vaya, J., Khatib, S., Loboda, Y., & Finberg, J. P. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.023 · Cited by 27 · see citing works

A low blood copper concentration is a co-morbidity burden factor in Parkinson’s disease development

Ilyechova, E. Y., Miliukhina, I. V., Orlov, I. A., Muruzheva, Z. M., Puchkova, L. V., & Karpenko, M. N. (2017) · Neuroscience Research · doi:10.1016/j.neures.2017.11.011 · Cited by 27 · see citing works

Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs

Gatta, L., Cardinale, A., Wannenes, F., Consoli, C., Armani, A., Molinari, F., Mammi, C., Stocchi, F., Torti, M., Rosano, G. M. C., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.003 · Cited by 24 · see citing works

Brain Iron Dysregulation and the Risk of Ageing White Matter Lesions

Gebril, O. H., Simpson, J. E., Kirby, J., Brayne, C., & Ince, P. G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8161-y · Cited by 22 · see citing works

In Absence of the Cellular Prion Protein, Alterations in Copper Metabolism and Copper-Dependent Oxidase Activity Affect Iron Distribution

Gasperini, L., Meneghetti, E., Legname, G., & Benetti, F. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00437 · Cited by 22 · see citing works

Parkinson's disease – the continuing search for biomarkers

Breen, D. P., Michell, A. W., & Barker, R. A. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.080 · Cited by 21 · see citing works

Levodopa-induced dyskinesias in Parkinson’s disease increase cerebrospinal fluid nitric oxide metabolites’ levels

Santos‐Lobato, B. L., Bortolanza, M., Pinheiro, L. C., Batalhão, M. E., Pimentel, Â. V., Cárnio, E. C., Bel, E. A. D., & Tumas, V. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02447-4 · Cited by 21 · see citing works

Metallomics Applied to the Study of Neurodegenerative and Mental Diseases

Sussulini, A., & Hauser‐Davis, R. A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-90143-5_2 · Cited by 21 · see citing works

Different roles of radical scavengers – ascorbate and urate in the cerebrospinal fluid of amyotrophic lateral sclerosis patients

Spasojević, I., Stević, Z., Nikolić‐Kokić, A., Jones, D. R., Blagojević, D. P., & Spasić, M. B. (2010) · Redox Report · doi:10.1179/174329210x12650506623320 · Cited by 21 · see citing works

Behavioral and Neurotransmitter Abnormalities in Mice Deficient for Parkin, DJ-1 and Superoxide Dismutase

Hennis, M. R., Seamans, K. W., Marvin, M. A., Casey, B. H., & Goldberg, M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084894 · Cited by 21 · see citing works

Innovative Biomarkers for Alzheimer’s Disease: Focus on the Hidden Disease Biomarkers

Ghidoni, R., Squitti, R., Siotto, M., & Benussi, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170953 · Cited by 20 · see citing works

A Low-Molecular-Weight Ferroxidase Is Increased in the CSF of sCJD Cases: CSF Ferroxidase and Transferrin as Diagnostic Biomarkers for sCJD

Haldar, S., Beveridge, A. J., Wong, J., Singh, A., Galimberti, D., Borroni, B., Zhu, X., Blevins, J. E., Greenlee, J. J., Perry, G. L., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5032 · Cited by 20 · see citing works

Time-course of oxidation of lipids in human cerebrospinal fluidin vitro

Arlt, S., Finckh, B., Beisiegel†, U., & Kontush, A. (2000) · Free Radical Research · doi:10.1080/10715760000300111 · Cited by 27 · see citing works

PROTEINS MODIFICATIONS FOSTERED BY THE PRO-OXIDANT ENVIRONMENT OF PARKINSON�S AND ALZHEIMER�S DISEASES CEREBROSPINAL FLUID: THE CERULOPLASMIN CASE

Barbariga, M. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/barbariga-marco_phd2014-01-21

Verbal fluency activates the left medial temporal lobe: A functional magnetic resonance imaging study

Pihlajam�ki, M., Tanila, H., H�nninen, T., Könönen, M., Laakso, M. P., Partanen, K. P. L., Soininen, H. S., & Aronen, H. J. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 210 · see citing works

Systemic Oxidative Stress in Patients with Neurodegenerative Diseases

Repetto, M. G., & Boveris, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-45865-6_22 · Cited by 3 · see citing works

Novel biomarker for neurodegenerative diseases- motor neuron disease (MND), cerebellar ataxia (CA) and Parkinson's disease (PD)

Pandey, S., Singh, B., Yadav, S. K., & Mahdi, A. A. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.07.021 · Cited by 20 · see citing works